Indenolol effectively reduces BP without adverse metabolic effects

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1989

Schlagwörter:	Glucose Lipid Hypertension Lipid Metabolism Metabolic Effect

Anmerkung:	© Adis International Ltd 1989

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 689(1989), 1 vom: Juni, Seite 8-8
Übergeordnetes Werk:	volume:689 ; year:1989 ; number:1 ; month:06 ; pages:8-8

Links:	Volltext

DOI / URN:	10.1007/BF03320277

Katalog-ID:	SPR035979747

Internformat


LEADER	01000caa a22002652 4500
001	SPR035979747
003	DE-627
005	20230519140130.0
007	cr uuu---uuuuu
008	201007s1989 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/BF03320277 \|2 doi
035			\|a (DE-627)SPR035979747
035			\|a (SPR)BF03320277-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Indenolol effectively reduces BP without adverse metabolic effects
264		1	\|c 1989
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1989
650		4	\|a Glucose \|7 (dpeaa)DE-He213
650		4	\|a Lipid \|7 (dpeaa)DE-He213
650		4	\|a Hypertension \|7 (dpeaa)DE-He213
650		4	\|a Lipid Metabolism \|7 (dpeaa)DE-He213
650		4	\|a Metabolic Effect \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 689(1989), 1 vom: Juni, Seite 8-8 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:689 \|g year:1989 \|g number:1 \|g month:06 \|g pages:8-8
856	4	0	\|u https://dx.doi.org/10.1007/BF03320277 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 689 \|j 1989 \|e 1 \|c 06 \|h 8-8

Indexfelder

matchkey_str	article:22306056:1989----::neooefcieyeuebwtotdes
hierarchy_sort_str	1989
publishDate	1989
allfields	10.1007/BF03320277 doi (DE-627)SPR035979747 (SPR)BF03320277-e DE-627 ger DE-627 rakwb eng Indenolol effectively reduces BP without adverse metabolic effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Glucose (dpeaa)DE-He213 Lipid (dpeaa)DE-He213 Hypertension (dpeaa)DE-He213 Lipid Metabolism (dpeaa)DE-He213 Metabolic Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 689(1989), 1 vom: Juni, Seite 8-8 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:689 year:1989 number:1 month:06 pages:8-8 https://dx.doi.org/10.1007/BF03320277 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 689 1989 1 06 8-8
spelling	10.1007/BF03320277 doi (DE-627)SPR035979747 (SPR)BF03320277-e DE-627 ger DE-627 rakwb eng Indenolol effectively reduces BP without adverse metabolic effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Glucose (dpeaa)DE-He213 Lipid (dpeaa)DE-He213 Hypertension (dpeaa)DE-He213 Lipid Metabolism (dpeaa)DE-He213 Metabolic Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 689(1989), 1 vom: Juni, Seite 8-8 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:689 year:1989 number:1 month:06 pages:8-8 https://dx.doi.org/10.1007/BF03320277 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 689 1989 1 06 8-8
allfields_unstemmed	10.1007/BF03320277 doi (DE-627)SPR035979747 (SPR)BF03320277-e DE-627 ger DE-627 rakwb eng Indenolol effectively reduces BP without adverse metabolic effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Glucose (dpeaa)DE-He213 Lipid (dpeaa)DE-He213 Hypertension (dpeaa)DE-He213 Lipid Metabolism (dpeaa)DE-He213 Metabolic Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 689(1989), 1 vom: Juni, Seite 8-8 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:689 year:1989 number:1 month:06 pages:8-8 https://dx.doi.org/10.1007/BF03320277 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 689 1989 1 06 8-8
allfieldsGer	10.1007/BF03320277 doi (DE-627)SPR035979747 (SPR)BF03320277-e DE-627 ger DE-627 rakwb eng Indenolol effectively reduces BP without adverse metabolic effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Glucose (dpeaa)DE-He213 Lipid (dpeaa)DE-He213 Hypertension (dpeaa)DE-He213 Lipid Metabolism (dpeaa)DE-He213 Metabolic Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 689(1989), 1 vom: Juni, Seite 8-8 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:689 year:1989 number:1 month:06 pages:8-8 https://dx.doi.org/10.1007/BF03320277 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 689 1989 1 06 8-8
allfieldsSound	10.1007/BF03320277 doi (DE-627)SPR035979747 (SPR)BF03320277-e DE-627 ger DE-627 rakwb eng Indenolol effectively reduces BP without adverse metabolic effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Glucose (dpeaa)DE-He213 Lipid (dpeaa)DE-He213 Hypertension (dpeaa)DE-He213 Lipid Metabolism (dpeaa)DE-He213 Metabolic Effect (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 689(1989), 1 vom: Juni, Seite 8-8 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:689 year:1989 number:1 month:06 pages:8-8 https://dx.doi.org/10.1007/BF03320277 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 689 1989 1 06 8-8
language	English
source	Enthalten in Inpharma weekly 689(1989), 1 vom: Juni, Seite 8-8 volume:689 year:1989 number:1 month:06 pages:8-8
sourceStr	Enthalten in Inpharma weekly 689(1989), 1 vom: Juni, Seite 8-8 volume:689 year:1989 number:1 month:06 pages:8-8
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Glucose Lipid Hypertension Lipid Metabolism Metabolic Effect
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1989-06-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035979747
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035979747</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519140130.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1989 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03320277</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035979747</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03320277-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Indenolol effectively reduces BP without adverse metabolic effects</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1989</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1989</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glucose</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid Metabolism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">689(1989), 1 vom: Juni, Seite 8-8</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:689</subfield><subfield code="g">year:1989</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:8-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03320277</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">689</subfield><subfield code="j">1989</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">8-8</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Indenolol effectively reduces BP without adverse metabolic effects Glucose (dpeaa)DE-He213 Lipid (dpeaa)DE-He213 Hypertension (dpeaa)DE-He213 Lipid Metabolism (dpeaa)DE-He213 Metabolic Effect (dpeaa)DE-He213
topic	misc Glucose misc Lipid misc Hypertension misc Lipid Metabolism misc Metabolic Effect
spellingShingle	misc Glucose misc Lipid misc Hypertension misc Lipid Metabolism misc Metabolic Effect Indenolol effectively reduces BP without adverse metabolic effects
topic_unstemmed	misc Glucose misc Lipid misc Hypertension misc Lipid Metabolism misc Metabolic Effect
topic_browse	misc Glucose misc Lipid misc Hypertension misc Lipid Metabolism misc Metabolic Effect
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Indenolol effectively reduces BP without adverse metabolic effects
ctrlnum	(DE-627)SPR035979747 (SPR)BF03320277-e
title_full	Indenolol effectively reduces BP without adverse metabolic effects
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1989
contenttype_str_mv	txt
container_start_page	8
container_volume	689
format_se	Elektronische Aufsätze
doi_str_mv	10.1007/BF03320277
title_sort	indenolol effectively reduces bp without adverse metabolic effects
title_auth	Indenolol effectively reduces BP without adverse metabolic effects
abstract	© Adis International Ltd 1989
abstractGer	© Adis International Ltd 1989
abstract_unstemmed	© Adis International Ltd 1989
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Indenolol effectively reduces BP without adverse metabolic effects
url	https://dx.doi.org/10.1007/BF03320277
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/BF03320277
up_date	2024-07-03T16:15:33.790Z
_version_	1803575187257425920
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035979747</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519140130.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1989 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03320277</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035979747</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03320277-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Indenolol effectively reduces BP without adverse metabolic effects</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1989</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1989</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glucose</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid Metabolism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">689(1989), 1 vom: Juni, Seite 8-8</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:689</subfield><subfield code="g">year:1989</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:8-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03320277</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">689</subfield><subfield code="j">1989</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">8-8</subfield></datafield></record></collection>
score	7.4002314

Nicht das Richtige dabei?

Schreiben Sie uns!

Indenolol effectively reduces BP without adverse metabolic effects

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?